Europe Organ Preservation Market to Reach US$ 114.2 Million by 2032, Impelled by Increasing Incidences of Organ Failures

According to the latest report by IMARC Group, titled "Europe Organ Preservation Market Report by Preservation Solution (UW Solution, Custodiol HTK, Perfadex, and Others), Organ Donation Type (Living Organ Donation, Deceased Organ Donation), Technique (Static Cold Storage Technique, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidney, Liver, Lung, Heart, and Others), End-User (Hospitals and Clinics, Organ Banks, and Others), and Country 2024-2032," the Europe organ preservation market reached a value of US$ 69.3 Million in 2023. Organ preservation refers to the techniques and methods to keep organs viable outside the human body while waiting for transplantation. The goal of organ preservation is to preserve the quality and function of the organ, which is critical to the success of the transplant. Several methods are employed for organ preservation, including hypothermic preservation, which involves cooling the organ to reduce its metabolic activity, and normothermic preservation, which maintains the organ at body temperature and provides it with oxygen and nutrients. Organ preservation is critical for successful transplantation and has significantly enhanced the survival rates of transplant recipients. Continual advances in organ preservation techniques will continue to improve outcomes for transplant patients in the future. 

Europe Organ Preservation Market Trends:

The market in Europe is majorly driven by the increasing demand for organ transplantation. In line with this, the rising need for efficient preservation techniques to ensure better transplant outcomes is significantly contributing to market growth across the globe. Furthermore, the growing awareness and adoption of organ transplantation are positively influencing the market. Apart from this, the key companies are focusing on developing innovative preservation solutions and expanding their product portfolio to meet the accelerating demand for organ preservation. Moreover, the escalating incidences of organ failure and the increasing number of organ donors are catalyzing the market. Besides, the rising geriatric population and the growing initiatives by governments and local bodies to encourage organ donation are propelling the market. Additionally, governments across European countries are also focusing on strengthening their healthcare infrastructure to provide improved healthcare facilities. These developments are offering numerous opportunities for market expansion. The growing cases of chronic liver diseases and cirrhosis are bolstering the market. Some of the other factors driving the market growth include the introduction of innovative healthcare technologies, better reimbursement policies, increasing healthcare expenditure, and the high prevalence of chronic kidney diseases and heart failure. On account of the factors above, the market is anticipated to reach a value of US$ 114.2 Million by 2032, exhibiting a CAGR of 5.5% during 2024-2032. 

Market Summary:

• On the basis of the preservation solution, the market has been categorized into UW Solution, Custodiol HTK, Perfadex, and others.
• Based on the organ donation type, the market has been classified into living organ donation and deceased organ donation.
• Based on the technique, the market has been segmented into static cold storage technique, hypothermic machine perfusion, normothermic machine perfusion, and others.
• Based on the organ type, the market has been categorized into kidney, liver, lung, heart, and others.
• Based on the end-user, the market has been classified into hospitals and clinics, organ banks, and others.
• On the basis of the country, the market has been divided into Germany, France, the United Kingdom, Italy, Spain, and others.
• The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

Report Scope:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800